Michael Messinger
Chief Financial OfficerMr. Michael Messinger, C.P.A., also known as Mike, is President and Chief Executive Officer at ContraFect Corporation since November 15, 2023. He has been Chief Financial Officer of ContraFect Corp. since November 12, 2018 and serves as its Chief Accounting Officer. Mr. Messinger served as the Senior Vice President of Finance at ContraFect Corporation since October 01, 2016 until November 2018. Mr. Messinger served as the Vice President of Finance at ContraFect Corporation since November 2012 until October 01, 2016 and served as its Chief Accounting Officer until October 01, 2016. Mr. Messinger has years of experience in finance, accounting and forecasting for clinical development. He served as Controller of Coelacanth Corporation prior to his role as Director of Finance for Lexicon Pharmaceuticals, Inc since August 2016. In this capacity, he was responsible for the financial management of Lexicon’s partnership with Symphony Capital, LLC, in addition to coordinating fiscal and program management concerning Lexicon’s development programs. He started his career as an auditor at Ernst & Young, LLP. He received his B.B.A degree in accounting from the University of Michigan.
Positions
- Company NameSeaStar Medical Holding CorporationStock CodeICUPositionChief Financial OfficerRelated SecuritiesColleagues
- ESEric SchlorffCEO, Treasurer, President & Executive Director
- JAJennifer A. BairdIndependent Chairman of the Board
- MMMichael MessingerChief Financial Officer
- KCKevin ChungChief Medical Officer
- HDH. David HumesCo-Founder & Scientific Advisor
- TMTom MullenVice President of Operations & Product Development
- JNJohn NeumanIndependent Director
- GMGlenn Matthew ChertowMember of Medical Advisory Board
- RLRavindra L. MehtaMember of Medical Advisory Board
- Company NameContraFect CorporationStock CodeCFRXQPositionCEO, President, CFO & Principal Accounting OfficerColleagues
- RJRoger James PomerantzChairman
- NBNatalie BogdanosGeneral Counsel, Corporate Secretary & Data Protection Officer
- MSMatthew SalamoneVice President of Human Resources
- GWGary WoodnuttSenior Vice President of Translational Sciences & Preclinical Development
- WGWilliam Garrett NicholsInterim Chief Medical Officer
- SCSteven C. GilmanVice Chairman
- VAVincent A. FischettiChairman of Scientific Advisory Board
- SJSol J. BarerLead Independent Director
- DNDavid N. LowIndependent Director
